Author:
Quadri Mohammed Qudrathulla Khan,Annamaraju Sai Sandeep,Kancha Rama Krishna
Publisher
Springer Nature Singapore
Reference52 articles.
1. Hsu CH, Chan JK, Yin CH, Lee CC, Chern CU, Liao CI. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One. 2019;14(12):e0227197.
2. Bakhos CT, Salami AC, Kaiser LR, Petrov RV, Abbas AE. Thymic neuroendocrine tumors and thymic carcinoma: demographics, treatment, and survival. Innovations. 2020;15(5):468–74.
3. Koizumi T, Otsuki K, Tanaka Y, Noguchi T, Fukushuima T, Kobayashi T, Ozawa T, Sekiguchi N, Hamanaka K. National incidence and initial therapy for thymic carcinoma in Japan: based on analysis of hospital-based cancer registry data, 2009–2015. Jpn J Clin Oncol. 2020;50(4):434–9.
4. Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5(10):S260–5.
5. Eriksson M, Kaerlev L, Johansen P, Afonso N, Ahrens W, Costa-Pereira A, Guénel P, Jöckel KH, Gonzalez AL, Merletti F, Suárez-Varela MM. Tobacco smoking and alcohol consumption as risk factors for thymoma–a European case-control study. Cancer Epidemiol. 2019;61:133–8.